All Articles
BPC-157 for Pelvic Organ Prolapse After GLP-1 Rapid Weight Loss
Rapid GLP-1 weight loss may reveal pelvic organ prolapse, but can BPC-157 strengthen connective tissue? We examine the preclinical promise and
BPC-157 for Female Alcohol Use Disorder: Can It Support Recovery?
BPC-157 shows preclinical promise for alcohol use disorder, but human evidence is absent. This article examines what research says about BPC-157
BPC-157 for C-Section Scar Recovery: What the FDA Peptide Panel Vote Means for Women's Access
This is an editorial discussion of published research. It is not a treatment plan. The recent FDA advisory panel vote on BPC-157, a synthetic peptide
BPC-157 for Postpartum Healing: FDA Panel Vote Impact
BPC-157 is gaining attention for postpartum healing, but the FDA's peptide vote highlights a lack of evidence. This article examines what's known, what's
Intranasal Oxytocin After Tirzepatide: Binge Eating Relapse
When tirzepatide is stopped, binge eating often returns. Could intranasal oxytocin prevent relapse? We examine the neuroendocrine evidence, gaps, and
Oxytocin and Semaglutide Menstrual Changes: Can Intranasal Oxytocin Help?
Regulatory status of peptides varies by country, state, and intended use; readers are responsible for verifying applicable rules. Semaglutide, a GLP-1